{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T21:00:08Z","timestamp":1776286808149,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1056,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.rmed.2010.04.004","type":"journal-article","created":{"date-parts":[[2010,8,15]],"date-time":"2010-08-15T04:44:18Z","timestamp":1281847458000},"page":"1425-1435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Montelukast added to fluticasone propionate does not alter inflammation or outcomes"],"prefix":"10.1016","volume":"104","author":[{"given":"Ratko","family":"Djukanovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan J.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy C.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Laviolette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene R.","family":"Bleecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Bruce","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis E.","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Olivenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliott","family":"Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mani S.","family":"Kavuru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Kleerup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna S.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven W.","family":"Yancey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa D.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Stauffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"Dorinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nizar N.","family":"Jarjour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.rmed.2010.04.004_bib1","first-page":"1l","article-title":"Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma","volume":"58","author":"British Thoracic Society","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2010.04.004_bib2","series-title":"From the global strategy for asthma management and prevention","article-title":"Global strategy for asthma management and prevention","author":"GINA Report","year":"2006"},{"key":"10.1016\/j.rmed.2010.04.004_bib3","series-title":"Executive summary of the NAEEP expert panel report 3: guidelines for the diagnosis and management of asthma","author":"National Asthma Education and Prevention Program","year":"2007"},{"key":"10.1016\/j.rmed.2010.04.004_bib4","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1164\/ajrccm\/147.6_Pt_1.1557","article-title":"Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids","volume":"147","author":"Sousa","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.rmed.2010.04.004_bib5","first-page":"124","article-title":"Bronchial biopsy study in asthmatics treated with low and high-dose fluticasone propionate (FP) compared to low-dose FP combined with salmeterol","volume":"S30","author":"Sue-Chu","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2010.04.004_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bjp.0706736","article-title":"How corticosteroids control inflammation: Quintiles Prize lecture 2005","volume":"148","author":"Barnes","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.rmed.2010.04.004_bib7","doi-asserted-by":"crossref","first-page":"S427","DOI":"10.1016\/S0091-6749(98)70154-X","article-title":"Current issues for establishing inhaled corticosteroids as the anti-inflammatory agents of choice in asthma","volume":"101","author":"Barnes","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmed.2010.04.004_bib8","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1164\/ajrccm.157.5.9609014","article-title":"Effect of zafirlukast (Accolate) on cellular mediators of inflammation","volume":"157","author":"Calhoun","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2010.04.004_bib9","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1164\/ajrccm.161.4.9904026","article-title":"Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics","volume":"61","author":"Hasday","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2010.04.004_bib10","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1164\/ajrccm.160.6.9803042","article-title":"Montelukast added to inhaled beclomethasone in treatment of asthma","volume":"160","author":"Laviolette","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2010.04.004_bib11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/thorax.58.3.204","article-title":"Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma","volume":"58","author":"Vaquerizo","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2010.04.004_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM199901213400306","article-title":"Treatment of asthma with drugs modifying the leukotriene pathway","volume":"340","author":"Drazen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2010.04.004_bib13","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1183\/09031936.06.00102605","article-title":"Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness","volume":"27","author":"Green","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2010.04.004_bib14","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"issue":"Suppl. 37","key":"10.1016\/j.rmed.2010.04.004_bib15","first-page":"9s","article-title":"Safety of sputum induction","volume":"20","author":"Pizzichini","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2010.04.004_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaci.2006.03.043","article-title":"Control of airway inflammation maintained at a lower steroid dose with 100\/50\u03bcg of fluticasone propionate\/salmeterol","volume":"118","author":"Jarjour","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmed.2010.04.004_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/10520299309105629","article-title":"Immunohistochemistry on resin sections: a comparison of resin embedding techniques for small mucosal biopsies","volume":"68","author":"Britten","year":"1993","journal-title":"Biotech Histochem"},{"key":"10.1016\/j.rmed.2010.04.004_bib18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1183\/09031936.98.12040811","article-title":"Variation in measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies","volume":"12","author":"Sullivan","year":"1998","journal-title":"Eur Resp J"},{"key":"10.1016\/j.rmed.2010.04.004_bib19","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1067\/mai.2001.119413","article-title":"Subjects with mild and moderate asthma respond to segmental allergen challenge with similar, reproducible, allergen specific inflammation","volume":"108","author":"Moore","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmed.2010.04.004_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1378\/chest.124.1.42","article-title":"Airway tissue mast cells in persistent asthma: predicator of treatment failure when patients discontinue inhaled corticosteroids","volume":"124","author":"Kraft","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2010.04.004_bib21","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1378\/chest.111.4.852","article-title":"Airways remodeling is a distinctive feature of asthma and is related to severity of disease","volume":"111","author":"Chetta","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2010.04.004_bib22","series-title":"An introduction to the bootstrap","author":"Efron","year":"1993"},{"key":"10.1016\/j.rmed.2010.04.004_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/thorax.57.4.309","article-title":"Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma","volume":"57","author":"Ward","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2010.04.004_bib24","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.rmed.2004.11.011","article-title":"Benefit from anti-inflammatory treatment during clinical remission of atopic asthma","volume":"99","author":"Van den Toorn","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2010.04.004_bib25","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/j.1365-2222.2005.02365.x","article-title":"Inter-relationships between airway inflammation, reticular basement membrane thickening and bronchial hyper-reactivity to methacholine in asthma; a systematic bronchoalveolar lavage and airway biopsy analysis","volume":"35","author":"Ward","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.rmed.2010.04.004_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00408-006-0007-2","article-title":"The effect of inhaled budesonide and formoterol on bronchial remodeling and HRCT features in young asthmatics","volume":"185","author":"Capraz","year":"2007","journal-title":"Lung"},{"key":"10.1016\/j.rmed.2010.04.004_bib27","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jaci.2009.02.034","article-title":"Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide\/formoterol","volume":"123","author":"Pavord","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmed.2010.04.004_bib28","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1164\/ajrccm.156.3.9610084","article-title":"Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid","volume":"156","author":"Laitinen","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2010.04.004_bib29","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1046\/j.1365-2222.1998.00277.x","article-title":"Inhaled corticosteroid reduced lamina reticularis of the basement by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma","volume":"28","author":"Hoshino","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.rmed.2010.04.004_bib30","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0091-6749(99)70379-9","article-title":"Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma","volume":"104","author":"Hoshino","year":"1999","journal-title":"J Allergy Clin Immuol"},{"key":"10.1016\/j.rmed.2010.04.004_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1164\/ajrccm.164.1.2006003","article-title":"Effect of a long-acting \u03b22-agonist over three months on airway wall vascular remodeling in asthma","volume":"164","author":"Orsida","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2010.04.004_bib32","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/ajrccm.162.4.9910051","article-title":"Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma","volume":"162","author":"Boulet","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2010.04.004_bib33","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1164\/ajrccm.155.6.9196087","article-title":"Effect of short-term treatment with low dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study","volume":"155","author":"Olivieri","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2010.04.004_bib34","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1164\/rccm.200208-783OC","article-title":"Effects of addition of montelukast to inhaled fluticasone propionate on airway inflammation","volume":"167","author":"O\u2019Sullivan","year":"2003","journal-title":"Am J Repir Crit Care Med"},{"key":"10.1016\/j.rmed.2010.04.004_bib35","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1164\/rccm.200206-509OC","article-title":"Effects of montelukast and budesonide on airway response and airway inflammation in asthma","volume":"166","author":"Leigh","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2010.04.004_bib36","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/S0140-6736(00)05113-8","article-title":"Addition of leukotrienes antagonists to therapy in chronic persistent asthma: a randomized double-blind placebo-controlled trial","volume":"357","author":"Robinson","year":"2001","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"10.1016\/j.rmed.2010.04.004_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/00003495-200363002-00004","article-title":"Effects of inhaled corticosteroids, leukotriene receptor antagonist, or both, plus long-acting beta2-agonist on asthma pathophysiology: a review of the current evidence","volume":"63","author":"Vignola","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.rmed.2010.04.004_bib38","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1164\/ajrccm\/145.3.669","article-title":"Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma","volume":"145","author":"Djukanovic","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.rmed.2010.04.004_bib39","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1164\/ajrccm.159.4.9806052","article-title":"Clinical Control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment","volume":"159","author":"Sont","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2010.04.004_bib40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1378\/chest.126.1.213","article-title":"The local side effects of inhaled corticosteroids: current understanding and review of the literature","volume":"126","author":"Ronald","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2010.04.004_bib41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1440-1843.2004.00555.x","article-title":"Addition of montelukast versus double dose of inhaled budesonide in moderate persistent asthma","volume":"9","author":"Yildrum","year":"2004","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2010.04.004_bib42","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1378\/chest.125.5.1693","article-title":"Leukotriene modifier vs inhaled corticosteroid in mild to moderate asthma: clinical and anti-inflammatory effects","volume":"125","author":"Perng","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2010.04.004_bib43","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.rmed.2007.03.007","article-title":"Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control","volume":"101","author":"Barnes","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2010.04.004_bib44","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/bmj.324.7353.1545","article-title":"Anti-leukotrienes as add-on therapy to inhaled glucocorticoids in patients with asthma: systematic review of current evidence","volume":"324","author":"Ducharme","year":"2002","journal-title":"Br Med J"},{"key":"10.1016\/j.rmed.2010.04.004_bib45","first-page":"CD003137","article-title":"Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma","volume":"1","author":"Ram","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmed.2010.04.004_bib46","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1183\/09031936.06.00102605","article-title":"Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness","volume":"27","author":"Green","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2010.04.004_bib47","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1513\/pats.200402-018MS","article-title":"Glucocorticoids supress inflammation but spare innate immune responses in airway epithelium","volume":"1","author":"Schleimer","year":"2004","journal-title":"Proc Am Thorc Soc"},{"key":"10.1016\/j.rmed.2010.04.004_bib48","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611110001575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611110001575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:01:34Z","timestamp":1760612494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611110001575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0954611110001575"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2010.04.004","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Montelukast added to fluticasone propionate does not alter inflammation or outcomes","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2010.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}